For: | Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer. World J Gastroenterol 2023; 29(10): 1569-1588 [PMID: 36970592 DOI: 10.3748/wjg.v29.i10.1569] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i10/1569.htm |
Number | Citing Articles |
1 |
Liuxu Yao, Wen Zhai, Zongming Jiang, Rui He, Weiying Xie, Yuhong Li, Yiyang Hu. The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the
NF-κB/HIF-1α Signaling Pathway. Anti-Cancer Agents in Medicinal Chemistry 2024; 24(11): 878 doi: 10.2174/0118715206283884240326170501
|
2 |
Yilin Yu, Haixia Wu, Liang Hong, Jianjian Qiu, Shiji Wu, Lingdong Shao, Cheng Lin, Zhiping Wang, Junxin Wu. A large population-based and validated study on the follow-up management and supportive strategy of locally advanced rectal cancer patients. Supportive Care in Cancer 2024; 32(10) doi: 10.1007/s00520-024-08860-1
|
3 |
Xinying Zhou, Yu Zhao, Rongchuan Zhao, Shaheryar Shafi, Yue Yang, Guangxing Liu, Song-Bai Liu. Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2023.178
|
4 |
Marwa Abdel Hamid, Lorenz M. Pammer, Theresa K. Lentner, Bernhard Doleschal, Rebecca Gruber, Florian Kocher, Elisabeth Gasser, Anna Jöbstl, Andreas Seeber, Arno Amann. Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?. Current Oncology Reports 2024; 26(10): 1258 doi: 10.1007/s11912-024-01583-w
|
5 |
Lunxi Liang, Xueer Yang, Shuoyi Yao, Xinmeng Li, Fen Wang. Identification of lactylation-associated fibroblast subclusters predicting prognosis and cancer immunotherapy response in colon cancer. Gene 2025; 940: 149220 doi: 10.1016/j.gene.2025.149220
|
6 |
Qi Liu, Yajuan Zhang, Huimin Li, Hong Gao, Yijie Zhou, Dakui Luo, Zezhi Shan, Yufei Yang, Junyong Weng, Qingguo Li, Weiwei Yang, Xinxiang Li. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01649-z
|
7 |
Yung-Fu Chang, Hsing-Hsang Wang, Chih-Wen Shu, Wei-Lun Tsai, Cheng-Hsin Lee, Chun-Lin Chen, Pei-Feng Liu. TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer. Current Issues in Molecular Biology 2023; 45(6): 4529 doi: 10.3390/cimb45060287
|
8 |
Vaagdevi Mukkavilli, Gnanasekaran Ramakrishnan, Koteswara Reddy Gujjula, Balachandran S, Sahiti Chamarthy, Janaki Ramaiah Mekala. Molecular Understanding and Pharmacological Potency of Plant-Derived Compounds in Colorectal Cancer (CRC): A Critical Analysis and Future Perspectives. Cell Biochemistry and Biophysics 2024; 82(3): 1777 doi: 10.1007/s12013-024-01370-1
|
9 |
Hedyieh Karbasforooshan, Hossein Rahimi, Omid Arasteh, Abolghasem Allahyari, Mehdi Varmaghani, Mahdi Jannati, Vahid Ghavami, Mahmoodreza Jaafari, Sepideh Elyasi. Evaluation of Oral Nano-Silymarin Formulation Efficacy in the Prevention of Hand-Foot Syndrome and Neuropathy Induced by XELOX or m-FOLFOX6 Regimens in Metastatic Colorectal Cancer: A Triple-Blinded, Randomized Clinical Trial. Iranian Journal of Pharmaceutical Research 2024; 23(1) doi: 10.5812/ijpr-152364
|
10 |
Carmine Pinto, Sara Lonardi, Evaristo Maiello, Erika Martinelli, Michele Prisciandaro, Lisa Salvatore, Andrea Sartore-Bianchi, Mario Scartozzi, Giuseppe Aprile, Chiara Cremolini, Alberto Sobrero. Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1502185
|
11 |
Francisco Cezar Aquino de Moraes, Anna Luíza Soares de Oliveira Rodrigues, Jonathan N. Priantti, Jhonny Limachi-Choque, Rommel Mario Rodríguez Burbano. Efficacy and Safety of Anti-EGFR Therapy Rechallenge in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-024-01128-1
|
12 |
Po-Jung Chen. Outcomes of upfront primary tumor resection in patients with synchronous RAS wild-type metastatic colorectal cancer. American Journal of Cancer Research 2024; 14(12): 5863 doi: 10.62347/DLWI1455
|
13 |
Pengcheng Wang, Wenjin Zhong, Qiaozhen Huang, Yuejia Zhu, Liquan Chen, Kai Ye. Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon Cancer. ACS Biomaterials Science & Engineering 2024; 10(5): 3136 doi: 10.1021/acsbiomaterials.3c01531
|
14 |
Fei Xing, Ning Liu, Can Wang, Xu-Dong Wang. Caffeic acid phenethyl ester promotes oxaliplatin sensitization in colon cancer by inhibiting autophagy. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-65409-2
|
15 |
Wen-Yu Luan, Hao Lin, Yan-Dong Miao. Recommendations for articles and reviews in colorectal cancer-related research at the year-end of 2023. World Journal of Gastroenterology 2024; 30(30): 3548-3553 doi: 10.3748/wjg.v30.i30.3548
|
16 |
Yanrong Zhan, Xianwen Cheng, Pingping Mei, Shufa Tan, Wenzhe Feng, Hua Jiang. Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12662-3
|
17 |
Qingzhe Wang, Min Yu, Shuang Zhang. The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies. Frontiers in Immunology 2025; 15 doi: 10.3389/fimmu.2024.1440830
|
18 |
Kartik Tulsian, Dhinal Thakker, Vivek K. Vyas. Overcoming chimeric antigen receptor-T (CAR-T) resistance with checkpoint inhibitors: Existing methods, challenges, clinical success, and future prospects : A comprehensive review. International Journal of Biological Macromolecules 2025; 306: 141364 doi: 10.1016/j.ijbiomac.2025.141364
|
19 |
Fengxiang Huang, Haiyan Yang, Wenguang Bao, Yehong Bin, Shengsheng Zhou, Man Wang, Xiaoping Lv. Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis. Clinical and Translational Oncology 2023; 26(2): 468 doi: 10.1007/s12094-023-03268-5
|
20 |
Wen-Tao Zhong, Yuan Lv, Qian-Yu Wang, Ran An, Gang Chen, Jun-Feng Du. Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report. World Journal of Gastrointestinal Oncology 2024; 16(5): 2219-2224 doi: 10.4251/wjgo.v16.i5.2219
|
21 |
Mengying Kou, Ying Deng. Circulating tumor DNA as a predictive biomarker for treatment response and survival in metastatic colorectal cancer. International Journal of Colorectal Disease 2024; 39(1) doi: 10.1007/s00384-024-04785-7
|
22 |
Ghizlane Rais, Farah Boutaagount, Rania Mokfi, Meryem Maskrout, Soundous Bennour, Chaymae Senoussi, Fadoua Rais, Laila Lahlou. The Safety and Effectiveness of Bevacizumab in Metastatic Colorectal Cancer With Unresectable Metastases: A Real-Life Study From the South of Morocco. Cureus 2024; doi: 10.7759/cureus.56733
|
23 |
平 盛. Progress in Surgical Treatment of Colorectal Cancer. Advances in Clinical Medicine 2023; 13(11): 17887 doi: 10.12677/ACM.2023.13112510
|
24 |
Gihan Elsisi, Hana Abdul Kareem, Abdelaziz Alaseiri, Abdullah Alsharm, Mohamed Al Garni, Hajer Al-Mudaiheem, Fouad Alnagar, Hazem Lotfy, Mohamed Ouda, Ahmed Elshehri. Costs of Adverse Event Management Associated with First-Line Cetuximab or Panitumumab in Metastatic Colorectal Cancer Patients in Saudi Arabia. Journal of Health Economics and Outcomes Research 2025; 12(1) doi: 10.36469/001c.130878
|
25 |
Qing Cao, Ye Tian, Zhiyi Deng, Fangfang Yang, Erfei Chen. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications. International Journal of Molecular Sciences 2024; 25(6): 3358 doi: 10.3390/ijms25063358
|
26 |
Edward Zheng, Marcin Włodarczyk, Andrzej Węgiel, Aleksandra Osielczak, Maria Możdżan, Laura Biskup, Agata Grochowska, Maria Wołyniak, Dominik Gajewski, Mateusz Porc, Kasper Maryńczak, Łukasz Dziki. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC. Frontiers in Surgery 2024; 11 doi: 10.3389/fsurg.2024.1398289
|
27 |
Jie Ni, Chu-Gen Wan, Zi-Qi Sui. Efficacy and safety of radiotherapy in patients with microsatellite stable or proficient mismatch repair colorectal cancer liver metastasis. World Journal of Gastrointestinal Oncology 2025; 17(3): 102873 doi: 10.4251/wjgo.v17.i3.102873
|
28 |
Jinyi Xu, Xiaoqiang Niu. Assessing the Therapeutic Value of Primary Tumor Resection in Colorectal Cancer Lung Metastases: A Dynamic Visualization Clinical Tool Constructed Based on the SEER Database. Journal of Gastroenterology and Hepatology 2025; doi: 10.1111/jgh.16911
|
29 |
Gihan Elsisi, Hana Kareem, Abdelaziz Alaseiri, Abdullah Alsharm, Mohamed Al Garni, Hajer Al-Mudaiheem, Fouad Alnagar, Hazem Lotfy, Mohamed Ouda, Ahmed Elshehri. Elsisi G, Abdul Kareem H, Alaseiri A, et al. Costs of Adverse Event Management Associated with First-Line Cetuximab or Panitumumab in Metastatic Colorectal Cancer Patients in Saudi Arabia.. Journal of Health Economics and Outcomes Research 2025; : 106 doi: 10.36469/jheor.2025.130878
|
30 |
Marco Colella, Andrea Iannucci, Claudia Maresca, Francesco Albano, Carmela Mazzoccoli, Federica Laudisi, Ivan Monteleone, Giovanni Monteleone. SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells. Cancers 2024; 16(13): 2370 doi: 10.3390/cancers16132370
|
31 |
Daniel M. DePietro, Xin Li, Susan M. Shamimi-Noori. Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?. Seminars in Interventional Radiology 2024; 41(01): 027 doi: 10.1055/s-0043-1777716
|
32 |
Umberto Malapelle, Valentina Angerilli, Rossana Intini, Francesca Bergamo, Chiara Cremolini, Federica Grillo, Elena Guerini Rocco, Tiziana Pia Latiano, Erika Martinelli, Nicola Normanno, Fabio Pagni, Paola Parente, Alessandro Pastorino, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Matteo Fassan. Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paper. Critical Reviews in Oncology/Hematology 2025; 206: 104574 doi: 10.1016/j.critrevonc.2024.104574
|
33 |
Xin Shen, Mengying Xiang, Jiadai Tang, Guangrui Xiong, Ke Zhang, Tingrong Xia, Zhengting Li, Shaoqiong Yang, Xiaoying Chai, Yao Huang, Lin Xie. Evaluation of peripheral blood inflammation indexes as prognostic markers for colorectal cancer metastasis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68150-y
|
34 |
Devanshi D. Patel, Paxton V. Dickson. Invited Editorial About: “Impact of Tumoral β2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer,” by C. Komine et al.. Annals of Surgical Oncology 2025; 32(3): 1412 doi: 10.1245/s10434-024-16609-7
|
35 |
Guillermo Valenzuela, Héctor R. Contreras, Katherine Marcelain, Mauricio Burotto, Jaime González-Montero. Understanding microRNA-Mediated Chemoresistance in Colorectal Cancer Treatment. International Journal of Molecular Sciences 2025; 26(3): 1168 doi: 10.3390/ijms26031168
|
36 |
Run-Zhi Deng, Xin Zheng, Zhong-Lei Lu, Ming Yuan, Qi-Chang Meng, Tao Wu, Yu Tian. Effect of colorectal cancer stem cells on the development and metastasis of colorectal cancer. World Journal of Gastrointestinal Oncology 2024; 16(11): 4354-4368 doi: 10.4251/wjgo.v16.i11.4354
|
37 |
Mohammad Arafat, Anthony Wignall, Kyle Brewer, Yunmei Song, Hugo Albrecht, Clive A. Prestidge, Sanjay Garg, Anton Blencowe. Comparison of polymer-coated, drug-eluting self-expandable metal stents for the potential treatment of gastrointestinal cancers. RSC Pharmaceutics 2025; doi: 10.1039/D4PM00312H
|